159 related articles for article (PubMed ID: 19216216)
21. LRIG1 is a prognostic biomarker in non-small cell lung cancer.
Kvarnbrink S; Karlsson T; Edlund K; Botling J; Lindquist D; Jirström K; Micke P; Henriksson R; Johansson M; Hedman H
Acta Oncol; 2015; 54(8):1113-9. PubMed ID: 25813475
[TBL] [Abstract][Full Text] [Related]
22. Sensitivity and specificity of epithelial membrane antigen staining patterns in ependymomas.
Hasselblatt M; Paulus W
Acta Neuropathol; 2003 Oct; 106(4):385-8. PubMed ID: 12898159
[TBL] [Abstract][Full Text] [Related]
23. Expression of claudins relates to tumour aggressivity, location and recurrence in ependymomas.
Nordfors K; Haapasalo J; Sallinen PK; Haapasalo H; Soini Y
Histol Histopathol; 2013 Sep; 28(9):1137-46. PubMed ID: 23423606
[TBL] [Abstract][Full Text] [Related]
24. Chromosome 1q gain and tenascin-C expression are candidate markers to define different risk groups in pediatric posterior fossa ependymoma.
Araki A; Chocholous M; Gojo J; Dorfer C; Czech T; Heinzl H; Dieckmann K; Ambros IM; Ambros PF; Slavc I; Haberler C
Acta Neuropathol Commun; 2016 Aug; 4(1):88. PubMed ID: 27550150
[TBL] [Abstract][Full Text] [Related]
25. The LRIG family: enigmatic regulators of growth factor receptor signaling.
Simion C; Cedano-Prieto ME; Sweeney C
Endocr Relat Cancer; 2014; 21(6):R431-43. PubMed ID: 25183430
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical markers for prognosis of ependymal neoplasms.
Korshunov A; Golanov A; Timirgaz V
J Neurooncol; 2002 Jul; 58(3):255-70. PubMed ID: 12187959
[TBL] [Abstract][Full Text] [Related]
27. Molecular genetics of ependymomas and pediatric diffuse gliomas: a short review.
Nobusawa S; Hirato J; Yokoo H
Brain Tumor Pathol; 2014 Oct; 31(4):229-33. PubMed ID: 25182241
[TBL] [Abstract][Full Text] [Related]
28. Expression profiling of ependymomas unravels localization and tumor grade-specific tumorigenesis.
Palm T; Figarella-Branger D; Chapon F; Lacroix C; Gray F; Scaravilli F; Ellison DW; Salmon I; Vikkula M; Godfraind C
Cancer; 2009 Sep; 115(17):3955-68. PubMed ID: 19536879
[TBL] [Abstract][Full Text] [Related]
29. Diagnostics of pediatric supratentorial RELA ependymomas: integration of information from histopathology, genetics, DNA methylation and imaging.
Pagès M; Pajtler KW; Puget S; Castel D; Boddaert N; Tauziède-Espariat A; Picot S; Debily MA; Kool M; Capper D; Sainte-Rose C; Chrétien F; Pfister SM; Pietsch T; Grill J; Varlet P; Andreiuolo F
Brain Pathol; 2019 May; 29(3):325-335. PubMed ID: 30325077
[TBL] [Abstract][Full Text] [Related]
30. Alterations of protein 4.1 family members in ependymomas: a study of 84 cases.
Rajaram V; Gutmann DH; Prasad SK; Mansur DB; Perry A
Mod Pathol; 2005 Jul; 18(7):991-7. PubMed ID: 15731777
[TBL] [Abstract][Full Text] [Related]
31. Ligand-specific regulation of transforming growth factor beta superfamily factors by leucine-rich repeats and immunoglobulin-like domains proteins.
Abdullah A; Herdenberg C; Hedman H
PLoS One; 2023; 18(8):e0289726. PubMed ID: 37603563
[TBL] [Abstract][Full Text] [Related]
32. Leucine-rich repeat and immunoglobulin domain-containing protein-1 (Lrig1) negative regulatory action toward ErbB receptor tyrosine kinases is opposed by leucine-rich repeat and immunoglobulin domain-containing protein 3 (Lrig3).
Rafidi H; Mercado F; Astudillo M; Fry WH; Saldana M; Carraway KL; Sweeney C
J Biol Chem; 2013 Jul; 288(30):21593-605. PubMed ID: 23723069
[TBL] [Abstract][Full Text] [Related]
33. Specific chromosomal imbalances as detected by array CGH in ependymomas in association with tumor location, histological subtype and grade.
Rousseau A; Idbaih A; Ducray F; Crinière E; Fèvre-Montange M; Jouvet A; Delattre JY
J Neurooncol; 2010 May; 97(3):353-64. PubMed ID: 19865800
[TBL] [Abstract][Full Text] [Related]
34. HYPOTHESIS: Do LRIG Proteins Regulate Stem Cell Quiescence by Promoting BMP Signaling?
Herdenberg C; Hedman H
Stem Cell Rev Rep; 2023 Jan; 19(1):59-66. PubMed ID: 35969315
[TBL] [Abstract][Full Text] [Related]
35. Intracranial ependymomas: molecular insights and translation to treatment.
Lester A; McDonald KL
Brain Pathol; 2020 Jan; 30(1):3-12. PubMed ID: 31433520
[TBL] [Abstract][Full Text] [Related]
36. Rare histological variants in ependymomas: histopathological analysis of 13 cases.
Gessi M; Kuchelmeister K; Lauriola L; Pietsch T
Virchows Arch; 2011 Oct; 459(4):423-9. PubMed ID: 21792667
[TBL] [Abstract][Full Text] [Related]
37. Spinal cord ependymomas and myxopapillary ependymomas in the first 2 decades of life: a clinicopathological and immunohistochemical characterization of 19 cases.
Stephen JH; Sievert AJ; Madsen PJ; Judkins AR; Resnick AC; Storm PB; Rushing EJ; Santi M
J Neurosurg Pediatr; 2012 Jun; 9(6):646-53. PubMed ID: 22656257
[TBL] [Abstract][Full Text] [Related]
38. Altered MicroRNA Expression Is Associated with Tumor Grade, Molecular Background and Outcome in Childhood Infratentorial Ependymoma.
Zakrzewska M; Fendler W; Zakrzewski K; Sikorska B; Grajkowska W; Dembowska-Bagińska B; Filipek I; Stefańczyk Ł; Liberski PP
PLoS One; 2016; 11(7):e0158464. PubMed ID: 27390862
[TBL] [Abstract][Full Text] [Related]
39. Expression of LRIG proteins as possible prognostic factors in primary vaginal carcinoma.
Ranhem C; Lillsunde Larsson G; Hedman H; Lindquist D; Karlsson MG; Hellström AC; Östensson E; Sorbe B; Hellman K; Andersson S
PLoS One; 2017; 12(8):e0183816. PubMed ID: 28841699
[TBL] [Abstract][Full Text] [Related]
40. Downregulation of LRIG1 expression by RNA interference promotes the aggressive properties of glioma cells via EGFR/Akt/c-Myc activation.
Xie R; Yang H; Xiao Q; Mao F; Zhang S; Ye F; Wan F; Wang B; Lei T; Guo D
Oncol Rep; 2013 Jan; 29(1):177-84. PubMed ID: 23124613
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
